CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy
โ Scribed by Diana M. Escolar; Gunnar Buyse; Erik Henricson; Robert Leshner; Julaine Florence; Jill Mayhew; Carolina Tesi-Rocha; Ksenija Gorni; Livia Pasquali; Kantilal M. Patel; Robert McCarter; Jennifer Huang; Thomas Mayhew; Tulio Bertorini; Jose Carlo; Anne M. Connolly; Paula R. Clemens; Nathalie Goemans; Susan T. Iannaccone; Masanori Igarashi; Yoram Nevo; Alan Pestronk; S. H. Subramony; V. V. Vedanarayanan; Henry Wessel
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 91 KB
- Volume
- 58
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Twenty-seven boys with Duchenne muscular dystrophy (DMD) entered a double-blind controlled trial of treatment with the calcium antagonist flunarizine. They were matched for age and disability. At monthly intervals, muscle power, functional ability, locomotor score, contractures, and forced vital cap
Fatigue in patients with mitochondrial cytopathies is associated with decreased basal and postactivity muscle phosphocreatine (PCr). Creatine monohydrate supplementation has been shown to increase muscle PCr and high-intensity power output in healthy subjects. We studied the effects of creatine mono